ArticleTranslational lung cancer research2023
Plasma-derived immune-related factors as biomarkers of osimertinib resistance in EGFR-mutant non-small cell lung cancer patients.
Per HydbringPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.